INM logo

InMed Pharmaceuticals (INM) Return On Assets

Annual ROA

-59.20%
-0.10%-0.17%

June 30, 2024


Summary


Performance

INM ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMprofitabilitymetrics:

Quarterly ROA

-55.13%
+3.50%+5.97%

September 30, 2024


Summary


Performance

INM Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

INM ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.2%-24.1%
3 y3 years+49.0%+55.7%
5 y5 years-6.7%+33.1%

INM ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.2%+64.1%-24.9%+55.7%
5 y5-year-6.7%+64.1%-24.9%+55.7%
alltimeall time-26.8%+85.6%-157.6%+98.0%

InMed Pharmaceuticals ROA History

DateAnnualQuarterly
Sep 2024
-
-55.13%(-6.0%)
Jun 2024
-59.20%(+0.2%)
-58.63%(+31.9%)
Mar 2024
-
-44.44%(+0.7%)
Dec 2023
-
-44.15%(-9.8%)
Sep 2023
-
-48.94%(-9.9%)
Jun 2023
-59.10%(-64.1%)
-54.34%(-47.7%)
Mar 2023
-
-103.88%(-3.0%)
Dec 2022
-
-107.10%(-11.0%)
Sep 2022
-
-120.27%(-3.3%)
Jun 2022
-164.83%(+42.0%)
-124.39%(+32.2%)
Mar 2022
-
-94.11%(-2.4%)
Dec 2021
-
-96.44%(-3.7%)
Sep 2021
-
-100.13%(-5.2%)
Jun 2021
-116.05%(+48.5%)
-105.67%(+15.9%)
Mar 2021
-
-91.21%(+10.7%)
Dec 2020
-
-82.42%(-1.1%)
Sep 2020
-
-83.35%(+2.3%)
Jun 2020
-78.15%(+40.9%)
-81.48%(-2.8%)
Mar 2020
-
-83.79%(+9.1%)
Dec 2019
-
-76.78%(+18.7%)
Sep 2019
-
-64.67%(+17.0%)
Jun 2019
-55.46%(+18.8%)
-55.29%(+8.8%)
Mar 2019
-
-50.83%(+5.6%)
Dec 2018
-
-48.13%(-5.9%)
Sep 2018
-
-51.15%(-10.6%)
Jun 2018
-46.70%(-47.8%)
-57.21%(-22.7%)
Mar 2018
-
-74.03%(-15.5%)
Dec 2017
-
-87.62%(-28.2%)
Sep 2017
-
-122.08%(-0.9%)
Jun 2017
-89.51%(-36.3%)
-123.23%(-8.5%)
Mar 2017
-
-134.70%(+1.9%)
Dec 2016
-
-132.17%(-0.3%)
Sep 2016
-
-132.63%(-10.2%)
Jun 2016
-140.55%(-40.5%)
-147.62%(-32.4%)
Mar 2016
-
-218.51%(-25.2%)
Dec 2015
-
-292.16%(+8.8%)
Sep 2015
-
-268.52%(+5.2%)
Jun 2015
-236.22%(+63.5%)
-255.18%(-14.2%)
Mar 2015
-
-297.50%(+21.4%)
Dec 2014
-
-245.07%(-11.9%)
Sep 2014
-
-278.25%(-22.5%)
Jun 2014
-144.47%(-19.0%)
-359.12%(-87.2%)
Mar 2014
-
-2806.56%(+141.2%)
Dec 2013
-
-1163.49%(+254.3%)
Sep 2013
-
-328.42%(+37.3%)
Jun 2013
-178.38%
-239.23%(-17.2%)
Mar 2013
-
-289.00%(+38.1%)
DateAnnualQuarterly
Dec 2012
-
-209.22%(+26.5%)
Sep 2012
-
-165.37%(+30.2%)
Jun 2012
-128.41%(-23.9%)
-127.02%(+246.0%)
Mar 2012
-
-36.71%(-67.3%)
Dec 2011
-
-112.25%(-4.9%)
Sep 2011
-
-118.00%(-8.0%)
Jun 2011
-168.64%(-59.0%)
-128.29%(-18.6%)
Mar 2011
-
-157.54%(-27.6%)
Dec 2010
-
-217.61%(-23.4%)
Sep 2010
-
-284.16%(-24.3%)
Jun 2010
-411.00%(+172.7%)
-375.14%(+72.8%)
Mar 2010
-
-217.04%(-22.6%)
Dec 2009
-
-280.43%(+9.1%)
Sep 2009
-
-257.06%(-15.9%)
Jun 2009
-150.70%(+45.8%)
-305.82%(+24.9%)
Mar 2009
-
-244.82%(+24.4%)
Dec 2008
-
-196.76%(-3.8%)
Sep 2008
-
-204.63%(+62.5%)
Jun 2008
-103.37%(-70.9%)
-125.95%(-45.7%)
Mar 2008
-
-231.88%(-22.2%)
Dec 2007
-
-298.05%(-26.4%)
Sep 2007
-
-404.91%(+9.9%)
Jun 2007
-355.31%(+128.5%)
-368.59%(+80.1%)
Mar 2007
-
-204.66%(-2.5%)
Dec 2006
-
-209.97%(+46.8%)
Sep 2006
-
-143.02%(+7.2%)
Jun 2006
-155.53%(-57.2%)
-133.43%(-24.8%)
Mar 2006
-
-177.36%(+37.2%)
Dec 2005
-
-129.23%(-11.3%)
Sep 2005
-
-145.70%(-17.9%)
Jun 2005
-363.08%(+104.2%)
-177.48%(+29.7%)
Mar 2005
-
-136.89%(-19.7%)
Dec 2004
-
-170.39%(-27.3%)
Sep 2004
-
-234.36%(+47.9%)
Jul 2004
-177.79%(+82.6%)
-158.44%(+25.9%)
Apr 2004
-
-125.87%(+2.1%)
Jan 2004
-
-123.33%(+5.6%)
Oct 2003
-
-116.82%(-0.3%)
Jul 2003
-97.39%(+8.4%)
-117.16%(+4.2%)
Apr 2003
-
-112.44%(+0.4%)
Jan 2003
-
-112.02%(+5.6%)
Oct 2002
-
-106.05%(-6.0%)
Jul 2002
-89.87%(-1.6%)
-112.77%(+43.6%)
Apr 2002
-
-78.52%(+65.2%)
Jan 2002
-
-47.52%(+122.1%)
Oct 2001
-
-21.40%
Jul 2001
-91.36%
-

FAQ

  • What is InMed Pharmaceuticals annual return on assets?
  • What is the all time high annual ROA for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual ROA year-on-year change?
  • What is InMed Pharmaceuticals quarterly return on assets?
  • What is the all time high quarterly ROA for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly ROA year-on-year change?

What is InMed Pharmaceuticals annual return on assets?

The current annual ROA of INM is -59.20%

What is the all time high annual ROA for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual return on assets is -46.70%

What is InMed Pharmaceuticals annual ROA year-on-year change?

Over the past year, INM annual return on assets has changed by -0.10% (-0.17%)

What is InMed Pharmaceuticals quarterly return on assets?

The current quarterly ROA of INM is -55.13%

What is the all time high quarterly ROA for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly return on assets is -21.40%

What is InMed Pharmaceuticals quarterly ROA year-on-year change?

Over the past year, INM quarterly return on assets has changed by -10.69% (-24.05%)